Aequus to supply Kensington Eye Institute with Zepto Capsulotomy system; Extends Distribution Agreement with Mynosys
23 mai 2019 08h45 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, May 23, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce an agreement for the Zepto...
Aequus Closes $2.35 Million Offering of Convertible Debenture Units
02 mai 2019 09h15 HE
|
Aequus Pharmaceuticals
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 02, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (“Aequus”...
Aequus to Present at Bloom Burton & Co. Healthcare Investor Conference on May 1, 2019
30 avr. 2019 10h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, April 30, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides Year End Financial Highlights
24 avr. 2019 23h36 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, April 24, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Signs Term Sheet for Five Preservative Free Dry Eye Products
07 mars 2019 08h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, March 07, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce the signing of a term sheet...
Aequus Signs Term Sheet with European Partner for a Preservative Free Therapeutic in Ophthalmology
17 déc. 2018 08h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce the signing of a term sheet...
Aequus Reports Largest Quarterly Revenue in Company History and Provides Management Update
29 nov. 2018 18h15 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Strengthens Clinical Experience on Strategic Advisory Board in Ophthalmology, and Adds Commercial and Regulatory Expertise
15 nov. 2018 08h45 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Hosts Live Webinar Demonstrating the Zepto® Capsulotomy System, Led by Dr. Ike Ahmed
13 nov. 2018 08h45 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus forms Strategic Advisory Board in Ophthalmology, Chaired by Dr. Ike Ahmed
05 nov. 2018 08h45 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...